Form 4 for IGC IGC Pharma, Inc.
Accepted 2026-01-20 00:00:00 ET · period of report 2026-01-19 · accession 0001185185-26-000218 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-20 | 2026-01-19 | IGC | PRINS RICHARD K | Dir | M - OptEx | $0.00 | +100.0K | 1.37M | +8% | $0 |
| D | 2026-01-20 | 2026-01-19 | IGC | PRINS RICHARD K | Dir | M - OptEx | $0.00 | -100.0K | 50.0K | -67% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-19 | M | A | 100,000 | $0.00 | 1,371,251 | D | — | — | (F1) On March 13, 2024, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved. |
| 2 | Derivative | Restricted Stock Units | 2026-01-19 | M | D | 100,000 | $0.00 | 50,000 | D | — · — to — | 100,000 Common Stock | (F1) On March 13, 2024, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved. (F2) Each restricted stock unit represents a right to receive one share of IGC common stock. |